![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 39, 30551-30555, September 29, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Posttranscriptional Control Group, Department of
Biomolecular Sciences, University of Manchester Institute of
Science and Technology, P. O. Box 88, Manchester M60 1QD, United Kingdom
Received for publication, May 26, 2000, and in revised form, June 30, 2000
The eukaryotic cap-binding complex eIF4F is an
essential component of the translational machinery. Recognition of the
mRNA cap structure through its subunit eIF4E is a requirement for
the recruitment of other translation initiation factors to the mRNA 5'-end and thereby for the attachment of the 40 S ribosomal subunit. In
this study, we have investigated the mechanistic basis of the observation that eIF4E binding to the cap is enhanced in the presence of the large eIF4F subunit, eIF4G. We show that eIF4E requires access
to both the mRNA 5'-cap and eIF4G to form stable complexes with
short RNAs. This stabilization can be achieved using fragments of eIF4G
that contain the eIF4E binding site but not the RNA recognition motifs.
Full-length eIF4G is shown to induce increased eIF4E binding to cap
analogues that do not contain an RNA body. Both results show that
interaction of eIF4G with the mRNA is not necessary to enhance cap
binding by eIF4E. Moreover, we show that the effect of binding of
full-length eIF4G on the cap affinity of eIF4E can be further modulated
through binding of Pab1 to eIF4G. These data are consistent with
a model in which heterotropic cooperativity underlies eIF4F function.
One of the first steps during the initiation of translation on
eukaryotic mRNAs is the recruitment of a translationally competent 40 S ribosomal subunit to the mRNA 5'-end. This is mediated by the
cap-binding complex known as eukaryotic initiation factor eIF4F. The
minimal cap-binding complex that can be isolated from all organisms
investigated so far comprises two proteins, eIF4E and eIF4G. Whereas
eIF4E manifests direct affinity for the cap structure (1), eIF4G serves
as a multipurpose adaptor capable of recruiting a number of necessary
activities to the mRNA 5'-end (2). The binding of eIF4G to the
ribosome-associated initiation factor eIF3 is thought to establish
physical contact between the mRNA and the 40 S ribosomal subunit
(3), whereas binding to the RNA helicase eIF4A was proposed to be
necessary for the disruption of secondary structure in the
5'-untranslated region (4). Interactions between eIF4G and the
poly(A)-binding protein Pab1 have been shown to be capable of promoting
circularization of mRNA (5) and to be responsible for the
synergistic effect of the 5'-cap and the 3'-poly(A) tail of mRNAs
on translation initiation (6, 7). In addition, eIF4G contains two
putative RNA recognition motifs (8) and, at least in mammalian cells,
binds to the eIF4E-phosphorylating kinase Mnk1 (9).
The interaction between eIF4E and eIF4G involves a conserved motif with
the consensus sequence Tyr-X-X-X-X-Leu- It is therefore of interest that binding of the cap-binding complex to
other initiation factors affects the stability of the eIF4E-cap
interaction. So far, there is experimental evidence for a mutual
reinforcement of the majority of interactions in the chain
5'-cap:eIF4E:eIF4G:Pab1:poly(A)-3' for initiation factors purified from
wheat germ (18, 19). For yeast and mammalian eIF4E, the binding of
different ligands (namely the eIF4E binding domain of eIF4G
(4G-BD4E), p20, and 4E-BP2) has been shown to enhance (to
differing degrees) the affinity of eIF4E for immobilized cap analogues
and short RNAs (14, 20). In contrast, a fluorescence study determining
the affinity of eIF4E in the presence of a 17-mer peptide comprising
the minimal binding motif of eIF4G found no significant change in the
equilibrium binding constant with soluble cap analogues (21). The
binding of this peptide to eIF4E does not alter the crystal structure
of this protein (12).
The interpretation of these, at first sight contradictory, findings is
further complicated by the fact that mammalian eIF4E shows strong
differences in its binding to several cap analogues and short RNAs, and
that there is currently considerable uncertainty as to the affinity
values for these interactions. Thus, one study found that the binding
constant with cap analogues was two times smaller than with RNAs
(Kd values are 2 × 10 Cooperativity effects in factors such as eIF4E could play a key role in
the mechanism and control of translation (17). It has been proposed
that, contrary to the cooperative model for eIF4E function (14), eIF4G
enhances the eIF4E-cap interaction solely by virtue of the stabilizing
influence of RNA binding to the eIF4G RRM regions (23). We have
therefore designed a series of experiments to investigate further the
proposed cooperative behavior of eIF4E, using a range of different
techniques as well as different domains of eIF4G. The strategy was
designed specifically to clarify the confusion arising from apparently
contradictory results reported in previous work.
Preparation of Proteins--
Purification of recombinant yeast
eIF4E from inclusion bodies was performed as described previously (24),
but 20 mM GDP was used to elute the protein from
m7GTP-Sepharose instead of 0.1 mM
m7GTP. The nucleotide was removed from protein-containing
fractions by dialysis overnight against 2000 volumes of buffer B (20 mM HEPES, pH 7.5, 1 M KCl) followed by dialysis
for 4 h against 2000 volumes of buffer A.
His6-tagged fragments of yeast eIF4G were purified as
described earlier (14). Full-length, His6-eIF4G1 was
expressed in SF9 insect cells and purified via heparin chromatography
(application of the cleared extract in 20 mM HEPES, pH 7.5, 30 mM KCl, 2 mM MgCl2, and elution
with a gradient of 30-500 mM KCl in the same buffer),
followed by standard nickel-chelate chromatography.
His6-tagged Pab1 was expressed in Escherichia
coli BL21(DE3) (hsdS gal ( RNA Transcription in Vitro--
Synthetic DNA primers with the
sequences 5'-GAATTGTAATACGACTCACTATAG-3' and
5'-TGATGTTGTTGTTGGTGTCTATAGTGAGTCGTATTACAA TTC-3' were used to generate
capped or uncapped RNAs as described previously (20, 24).
SPR Assays--
Surface Plasmon Resonance
(SPR)1 experiments were
performed on a BIA3000 (BIAcore) essentially as described earlier (20). The eluent buffer for all experiments was 20 mM
HEPES, pH 7.5, 100 mM KCl, 100 µg/ml wheat germ tRNAs
(Roche Molecular Biochemicals), and 0.005% surfactant p20
(BIAcore). For estimation of the equilibrium binding constant,
10 RNA Gel Shifts--
2 µg of eIF4E were mixed with equimolar
amounts of the respective binding partners, plus 1 µg/µl tRNAs and
20 units RNAsin in a final volume of 20 µl of buffer (20 mM HEPES, pH 7.5, 100 mM KCl, 2 mM
MgCl2). The mixture was left for 5 min at room temperature. The radiolabeled probe was added in a volume of 2 µl, and the mixture
again left for 5 min at room temperature. The samples were then
separated on a 10% polyacrylamide gel (19:1 acrylamide:bisacrylamide), with 75 mM Tris/glycine, pH 8, as running buffer.
Analytical m7GTP-Sepharose Chromatography--
These
experiments were performed as described earlier (14). Eluted proteins
were separated on an SDS-polyacrylamide gel electrophoresis gel,
visualized using silver staining, and quantified with a Bio-Rad GS-700
imaging densitometer and Bio-Rad molecular analyst software.
eIF4E-binding proteins were added as indicated to an amount equimolar
to the original 10 µg of eIF4E.
CD Spectra--
All circular dichroism (CD) spectra were
recorded on a Jasco J810-CD in quartz cuvettes with a path length of 1 mm. For each sample, four spectra were recorded at a sensitivity of 100 millidegrees and averaged. For sample preparation, proteins were
dialyzed into buffer containing 50 mM KPO4, pH
7.5, and 2 mM MgSO4. All proteins were diluted
to a concentration of 10 µM in the same buffer, and m7GpppG was added where appropriate to a concentration of
20 µM. Prior to measurements, samples were incubated on
ice for 30 min and allowed to reach ambient temperature for five
minutes immediately before the measurements.
Preparation of Cap Analogue-free eIF4E--
The commonly used
method for the purification of recombinant eIF4E employs
m7GTP immobilized on Sepharose as a highly specific
affinity matrix for the binding of eIF4E. The elution of eIF4E from
this resin is usually performed using buffer containing 0.1 mM soluble m7GTP. The cap analogue is then
removed by means of either dialysis or further chromatographic methods
(25).
However, the efficiency of removal of the cap analogue during the
purification of eIF4E has been questioned (21). It is important that
eIF4E utilized in mRNA cap binding studies is essentially cap
analogue-free, because any presence of a strongly binding cap analogue
would reduce the effective concentration of active eIF4E. In earlier
studies, mammalian eIF4E was shown to bind to nonmethylated nucleotides
with 20-30-fold lower affinity than to their methylated counterparts
(26). We therefore modified the standard method of elution of eIF4E
from the cap resin, utilizing nonmethylated GTP instead of
m7GTP, because the former should be more readily removed
from the cap-binding protein. We found that 20 mM GTP
elutes yeast eIF4E from m7GTP-Sepharose with similar
efficiency to 0.1 mM m7GTP (data not shown).
The eluted protein was then dialyzed overnight against 2000 volumes of buffer containing 1 M KCl, followed by dialysis for a further 4 h against the same volume of low salt buffer.
To show that dialysis efficiently removes the nucleotide, a small
aliquot of eIF4E was mixed with [ eIF4E Shows Rapid Binding and Release with Immobilized
mRNAs--
A capped, 19-mer RNA containing a single biotinylated
UTP near its 3'-end was immobilized on streptavidin-coated sensor chips to a response level of 100 resonance units and used in SPR
experiments (Fig. 2, A and
B; and see "Materials and Methods"). The injection of
the apo-form (noncap-bound) of yeast eIF4E over these chips revealed an
interaction that is characterized by rapid binding and release, as was
previously observed for the human protein (20). Injections in the
presence of 0.1 mM GTP or m7GTP,
respectively, showed that the methylated cap analogue completely prevents the association of eIF4E with the chip, whereas the
nonmethylated nucleotide has only a minor effect (Fig. 2C).
This indicates that the observed sensorgrams were generated solely by
cap binding and not by nonspecific interactions of the protein with the
negatively charged mRNA matrix.
We do not at present know the origin of the slower binding and release
phases following the initial rapid interaction. However, we found that
the maximum response (Rmax) for these events is independent of the amount of immobilized mRNA. This suggests that this phase does not arise directly from the eIF4E-cap interaction. Part
of it may stem from eIF4E molecules that are trapped in the dextran
and/or mRNA matrix after release from the mRNA caps.
In contrast, the rapid phases of the sensorgrams were dependent on both
the amount of immobilized mRNA and the concentration of injected
eIF4E. Inspection of the end points of the rapid phases at different
protein concentrations yielded an estimated equilibrium binding
constant of 3.6 × 10
The dissociation rates observed with this method could not be subjected
to standard analysis procedures using the BIAevaluation curve-fitting
software, because the short time from the end of injection to complete
release of eIF4E did not yield sufficient data points for a detailed
analysis. However, manual comparison of the actual curves with
simulated release curves for off rates between 0.1 and 1 s Interaction of eIF4E with Both the 5'-Cap and eIF4G Is Necessary
for Tight Binding to mRNA--
In a further procedure designed to
yield information about the interaction between eIF4E and the cap
structure, gel mobility shift experiments were conducted with
radiolabeled mRNA identical to that used in the SPR experiments,
but containing no biotinylated residue. As has already been observed
(5), yeast eIF4E alone is not sufficient to generate detectable signals
of shifted RNA in this type of assay (Fig.
3, lane 1). This is
understandable in light of the results obtained in the SPR experiments,
because a complex characterized by the observed low affinity and fast rate constants would not remain stably bound to the cap structures. However, the presence of a 17-kDa fragment of eIF4G comprising the
eIF4E binding site flanked by ~70 amino acids on each side (termed
here 4G-BD4E) leads to a clearly detectable shift, whereas the eIF4G
fragment alone does not interact detectably with the capped mRNA
(lanes 2 and 3). The ability of the eIF4G
fragment to induce the shift is likely to be linked solely to the
increased cap-binding affinity of the complex with eIF4E, because this
fragment lacks the RRM domains of eIF4G. Moreover, the presence of the cap analogue m7GTP completely prevents retardation of the
RNAs (lane 4), and no shift can be induced under identical
conditions when uncapped mRNA is used (lane 9).
We next investigated the properties of a mutant form of eIF4E with the
substitution W75R. The apo-form of this protein binds the cap structure
with an affinity similar to the wild type, but can no longer interact
with eIF4G (14). This mutant protein was unable to cause the band-shift
(lane 12). A slight smear of radioactivity above the free
probe in this lane stems most likely from residual interactions between
the eIF4G fragment and the mutated eIF4E. In conclusion, both the
availability of a cap structure and the eIF4G interaction are necessary
for eIF4E to be able to form a stable complex with mRNA.
In previous work, a fragment of eIF4G comprising only the 17-amino acid
region covering the eIF4E binding site has been shown to bind stably to
eIF4E (12). However, this peptide did not have the ability to
strengthen the interaction with the cap sufficiently to cause a
mobility shift (lanes 5 and 6).
m7GTP-Sepharose Binding Studies Using Larger Fragments
of eIF4G--
The first indications of enhanced cap binding in the
presence of fragments of eIF4G were obtained using equilibrium studies with purified proteins and m7GTP-Sepharose (14). The use of
immobilized cap analogues is particularly suited for the determination
of cooperative effects during cap binding, because the absence of an
RNA body excludes additive effects arising from the presence of
RNA-binding activities in the eIF4E binding partners. Briefly, a small
amount of eIF4E is incubated with a small amount of immobilized cap
analogue, and an equilibrium between cap-bound and -free eIF4E is
established through incubation in a large buffer volume. The amount of
eIF4E that can subsequently be eluted from the resin is then taken as an indicator for the affinity of the protein for the cap.
We used this method to obtain data on the influence of larger fragments
of eIF4G on the cap affinity of eIF4E (data summarized in Fig.
4). As was shown previously, the presence
of 4G-BD4E significantly displaces the equilibrium between soluble and
resin-associated eIF4E toward the cap-bound state. To our surprise, we
found that the complete N-terminal half of eIF4G (4G-Nt,
comprising both the eIF4E and Pab1 binding site, Fig. 1A)
had a much weaker effect on the recovery of eIF4E from the resin
compared with the 17-kDa fragment. This is consistent with observations
that larger fragments of eIF4G show a weaker interaction with eIF4E in
yeast two-hybrid experiments.2
Interestingly, the addition of Pab1 to this reaction restored the
ability of eIF4G to increase the association of eIF4E with the cap
analogue. The effect of 4G-Nt in a complex with Pab1 slightly surpassed
that of 4G-BD4E alone. The same effect was observed when complete
eIF4G1 purified from insect cells was used. Indeed, the combination of
complete eIF4G1 and Pab1 produced the strongest effect in this assay,
leading to a 3-fold increase in the amount of eIF4E recovered from the
column.
It was noted that the greatest increase in recovery observed in this
assay was less dramatic than the increase in the signal observed in the
gel shift experiments. We assume that this reflects differences in the
interactions between eIF4E and cap analogues as compared with those
between eIF4E and mRNAs. Recent fluorescence studies found that the
binding of free eIF4E to m7GTP, which was used in the
affinity resin experiments described here, is almost one order of
magnitude stronger than the binding to the larger cap analogue,
m7GpppG, which more closely resembles a capped mRNA.
However, we assume that the more dramatic results from our gel shift
experiments using capped mRNAs more closely reflect affinity
changes in vivo. Finally, we observed that, in
contrast to the larger eIF4G fragments, the 17-amino acid peptide
comprising the minimal eIF4E binding motif had only a very small effect
on the recovery of eIF4E, again confirming the results obtained in the
gel shift experiments.
CD Spectral Analysis Reveals Conformational Changes in eIF4E upon
Cap Binding--
The data presented here suggest that binding of eIF4E
to eIF4G leads to an effective increase of the former protein's
affinity for mRNA cap structures. Nothing is known, however, about
the structural basis for this effect. Inspection of the sequences of
eIF4Es from different organisms revealed an area of high conservation in the internal parts of eIF4E. It was suggested that this area forms
an allosteric tract, which might be involved in structural changes that
eIF4E undergoes upon interaction with its ligands (20).
To investigate whether such changes do indeed take place, CD
experiments were performed with free and cap-bound eIF4E. We compared the CD spectrum of buffer containing 10 µM
eIF4E, recorded between 198 and 250 nm in the presence and
absence of cap analogue (Fig.
5A). Upon the addition of
20 µM m7GpppG, the basic spectrum of eIF4E
undergoes changes between 220 and 235 nm. Consistent with earlier
studies (28), we did not find any absorbance of the free cap analogue
at these wavelengths. We conclude, therefore, that the observed changes
in the CD spectrum arise from conformational rearrangements within
eIF4E.
As expected, the eIF4E·eIF4G-BD4E complex shows a spectrum that is
significantly different from that of free eIF4E. However, upon addition
of the cap analogue this complex shows changes in the CD spectrum very
similar to those observed with eIF4E alone (Fig. 5B). This
suggests, but does not prove, that the conformational changes are
limited to a large extent to the eIF4E part of the cap complex and do
not extend into the 17-kDa domain of eIF4G used here. Taken together
with the data on the increased cap affinity of the eIF4F complex, these
results suggest that the eIF4G binding domain stabilizes conformational
rearrangements within eIF4E. Our data do not allow us to draw an
unequivocal conclusion regarding the influence of eIF4G-BD4E binding on
the conformation of apo-eIF4E.
The solving of the three-dimensional structure of eIF4E (15) has
recently provided a new basis for understanding how eIF4E interacts
with the cap structure. However, the initially assumed "static"
binding model, in which eIF4E interacts with the cap only in the
conformation deduced from the crystallographic data (12, 15), seems
unlikely to provide an adequate explanation of the functional
characteristics of this protein as part of eIF4F.
Most studies concerning the nature of cap binding by eIF4E assume a
relatively low affinity for capped mRNAs, with a
Keq of ~10 One explanation for this apparent discrepancy could be provided by the
fact that eIF4G itself shows affinity for mRNA through the action
of two weakly conserved RRMs in the C terminus of the protein (8).
Thus, eIF4F might be tied to the message through the combined action of
eIF4E and eIF4G. Indeed, increased cross-linking of human eIF4E to a
capped RNA in the presence of full-length eIF4G has been shown (30),
and it has been proposed that this increase is merely attributable to
the additional nonspecific eIF4G-mRNA interaction (23). In this
context, it is important to note that the binding of eIF4G to RNAs is
relatively weak, with an affinity measured for wheat eIF4G of
~10 The results reported here indicate that a different mechanism is
involved in the increased association with mRNAs when eIF4E is part
of eIF4F. The clearly observed increase in cap binding with fragments
of eIF4G that bind to eIF4E, but not to RNAs, as well as the increase
observed in binding to cap analogues that are not attached to an RNA
body, are fully consistent with a model in which binding of ligands to
the dorsal site on eIF4E modulates the affinity for the cap of this
protein. Of the fragments tested here, the minimal portion of eIF4G
capable of inducing this effect comprises the eIF4E binding site plus
~70 amino acids on either side. This explains earlier, apparently
contradictory results, which showed that no enhancement of cap binding
can be observed when a peptide corresponding only to the known eIF4E
binding motif is used (21). We have now seen that the corresponding
peptide fails to produce any clear effect using the techniques
described in this paper.
With larger portions of eIF4G, or the full-length protein, the
simultaneous presence of Pab1 was found to be necessary to achieve
maximum reinforcement of the eIF4E-cap interaction. A comparable effect
has been described for wheat eIF4F, where the presence of the
poly(A)-binding protein PAB was found to enhance the affinity of both
eIF4F and eIF(iso)4F for cap analogues (19).
The data presented in this study, together with results derived from
earlier studies (Table I), form a
considerable body of evidence supporting the notion that cooperative
effects play a role in the assembly and function of the cap-binding
complex eIF4F. The finding of cooperative effects is significant for
understanding how eIF4F can function during translation initiation
despite the potentially transient nature of the basic eIF4E-cap
interaction. Further work will have to address the role that
cooperativity plays during translation initiation in vivo,
and the way in which this might affect the overall process of
translation and its regulation.
We thank Anthea Scothern for expert
assistance with the purification of the proteins. The plasmid
expressing PAB1 was a kind gift of Dr. Alan Sachs (Berkeley).
*
This work was supported by the Biotechnology and Biological
Sciences Research Council (UK) (to T. v. d. H.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Published, JBC Papers in Press, July 7, 2000, DOI 10.1074/jbc.M004565200
2
M. Ptushkina and J. E. G. McCarthy,
unpublished results.
The abbreviations used are:
SPR, surface plasmon
resonance;
CD, circular dichroism;
4G-BO4E, eIF4E binding domain of
eIF4G (here, amino acids 348-513);
RRM, RNA Recognition motif;
4G-Nt, N-terminal domain of eIF4G (here, amino acids 1-513).
Stabilization of Eukaryotic Initiation Factor 4E Binding to the
mRNA 5'-Cap by Domains of eIF4G*
,
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
(where
is a
hydrophobic amino acid) in eIF4G (10-12); although it has been
suggested that intermolecular contacts involving further amino acids
outside this consensus sequence contribute to the stability of eIF4F
(13). In the case of eIF4E, a necessary but possibly not fully
sufficient binding motif has been identified corresponding to the
sequence Val-Glu-X-X-Trp (14), which is situated on the cap
distal surface of the protein in both yeast and mammalian eIF4E (15,
16). Because the interaction between these two motifs is required for
coupling the cap-binding activity to the activities of other initiation
factors, its disruption or reinforcement may be utilized by cells to
control specifically the translation of capped messages (see
e.g. Ref. 17).
6
M for m7GTP and m7GpppG and 1 × 10
6 M for capped RNAs, (22)). On the other
hand, a very recent study found equilibrium binding constants of 1 × 10
8 M for m7GTP and 2 × 10
7 M for the larger analogue,
m7GpppG (21).
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
cIts857 ind1
Sam7 nin5 lacUV5-T7 gene 1)) using the expression
plasmid pET2a at a growth temperature of 28 °C. Cells were lysed by
sonication, and the extract was subjected to nickel-chelate
chromatography. PAB1-containing fractions were pooled and subjected to
heparin chromatography as described for eIF4G.
7 to 10
5 M eIF4E in eluent
buffer was injected over the chip, and the equilibrium responses were
plotted against protein concentration. BIAevaluation software (v3.1;
BIAcore) was used to calculate a value corresponding to the curve.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
-32P]GTP and
subjected to the same procedure. Samples were taken after the initial
mixing as well as after each dialysis step, and cross-linking was
induced by irradiation with UV light. The resulting preparations were
subjected to SDS-polyacrylamide gel electrophoresis and autoradiography
(Fig. 1C). In addition, the eIF4E bands were visualized through Coomassie Blue staining and excised
from the gel, and the associated radioactivity was determined via
scintillation counting. Both results show that GTP can be removed from
the protein preparation with high efficiency, with the final protein
containing less than 0.5% of GTP-associated eIF4E as calculated from
the reduction of eIF4E-associated radioactivity.

View larger version (35K):
[in a new window]
Fig. 1.
A, fragments of Saccharomyces
cerevisiae eIF4G1 (p150) used in this study. Pep,
17-amino acid peptide corresponding to amino acids 449-465.
4G-BD4E, 17-kDa fragment corresponding to amino acids
348-513. 4G-Nt, 50-kDa fragment corresponding to amino
acids 1-513. B, purified proteins used in this study. 5 µg of each protein were loaded onto an SDS-polyacrylamide gel
electrophoresis gel and stained with Coomassie Blue. C,
removal of GTP from eIF4E. eIF4E was mixed with
[
-32P]GTP and subjected to the procedure used for the
removal of GTP after elution of eIF4E from cap analogue Sepharose. 3 µg of eIF4E were cross-linked to the nucleotide immediately after
mixing and after each dialysis step. The samples were then run on a
12.5% SDS-polyacrylamide gel electrophoresis gel and subjected to
autoradiography. The numbers shown were determined by
excision of the eIF4E bands from a Coomassie Blue-stained gel and
scintillation counting. wt, wild type.

View larger version (18K):
[in a new window]
Fig. 2.
A, the RNA used in the experiments.
B, RNA containing a single Biotin-21-UTP near the 3'-end was
immobilized on streptavidin-coated sensor chips. Purified recombinant
eIF4E was injected over these chips to monitor binding of the protein
to the mRNA caps. C, injection of free eIF4E
(black line, "on") leads to rapid binding of the protein
to the chip. The bound protein is rapidly released when the
protein-containing solution is replaced with buffer ("off"). In the
presence of cap analogue the association is completely prevented
(gray line), whereas GDP at the same concentration does not
strongly affect the association with the chip (broken gray
line).
6 M (data not
shown). This is in good accordance with the majority of published
results derived from fluorescence studies for capped RNAs and eIF4Es
from other species (e.g. 1 × 10
6
M for human eIF4E (22) and 0.8 × 10
6
M for wheat eIF4E (27)).
1 indicated that the release constant for the
eIF4E-mRNA interaction lies between 0.5 and 1 s
1,
corresponding to an association rate constant of 0.5-1 × 10
6 s
1 M
1.

View larger version (65K):
[in a new window]
Fig. 3.
Results of the mobility shift
experiments. A clear shift could only be obtained in the presence
of both eIF4E and 4G-BD4E (see arrow). This shift was
suppressed in the presence of cap analogue or if uncapped RNAs or a
mutant of eIF4E, which can no longer bind to eIF4G, were used. A
17-amino acid peptide comprising the minimal eIF4E binding motif of
eIF4G failed to produce any shift with capped RNAs. Wt, wild
type.

View larger version (17K):
[in a new window]
Fig. 4.
Recovery of eIF4E from
m7GTP-Sepharose in the absence and presence of different
fragments of yeast eIF4G1. The amount of eIF4E eluted in the
absence of any other protein was arbitrarily set to 100% and compared
with the amount eluted in the presence of the other proteins. The
white portions of the bars indicate the respective standard
deviations, whereas n indicates the number of independent
experiments used for the generation of each value.

View larger version (12K):
[in a new window]
Fig. 5.
CD spectra of eIF4E recorded in the presence
or absence of m7GpppG. The black lines
represent the spectrum of free eIF4E, whereas the gray lines
represent the spectrum recorded in the presence of the cap analogue.
Data were collected for eIF4E alone (A) and for the
eIF4E·4G-BD4E complex (B).
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
6 M. Such
a low affinity appears problematic with respect to the many functions
that eIF4G is thought to fulfill at the mRNA 5'-end, which may
include removal of secondary structure from the message by virtue of
the recruitment of eIF4A/4B, attachment of the ribosome via interaction
between eIF4G and eIF3, and according to a very recent study,
involvement in decapping of the message through recruitment of Dcp1
(29). These functions require a sequence of events to occur that are
firmly anchored at the 5'-end of the RNA, suggesting that a
sufficiently tight interaction between eIF4F and the mRNA is
important. The potential problem is further highlighted if one assumes
the operation of a very rapid binding cycle, especially with the rapid
release of eIF4E from capped RNA, as reported in this study. It seems
unlikely that a sequence of events as complex as the recruitment of the
40 S subunit could be tied to the RNA through an interaction that is
determined by the rate constants and affinity manifested by the
eIF4E-cap interaction alone.
6 M (27).
Apparent cooperativity effects during cap complex assembly reported in
the literature
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
To whom correspondence should be addressed: Posttranscriptional
Control Group, Department of Biomolecular Sciences, UMIST P.O. Box 88, Manchester M60 1QD, UK. Tel.: 0161 200 8913; Fax: 0161 200 8918;
E-mail: Tobias.von-der-Haar@umist.ac.uk.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
1.
Sonenberg, N.
(1996)
in
Translational Control
(Hershey, J. W. B.
, Matthews, M. B.
, and Sonenberg, N., eds)
, pp. 245-269, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
2.
Morley, S. J.,
Curtis, P. S.,
and Pain, V. M.
(1997)
RNA
3,
1085-1104
3.
Lamphear, B. J.,
Kirchweger, R.,
Skern, T.,
and Rhoads, R. E.
(1995)
J. Biol. Chem.
270,
21975-21983
4.
Rozen, F.,
Edery, I.,
Meerovitch, K.,
Dever, T. E.,
Merrick, W. C.,
and Sonenberg, N.
(1990)
Mol. Cell. Biol.
10,
1134-1144
5.
Wells, S. E.,
Hillner, P. E.,
Vale, R. E.,
and Sachs, A. B.
(1998)
Mol. Cell
2,
135-140
6.
Gallie, D. R.
(1991)
Genes Dev.
5,
2108-2116
7.
Tarun, S. Z., Jr.,
Wells, S. E.,
Deardorff, J. A.,
and Sachs, A. B.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
9046-9051
8.
Goyer, C.,
Altmann, M.,
Lee, H. S.,
Blanc, A.,
Deshmukh, M.,
Woolford, J. L.,
Trachsel, H.,
and Sonenberg, N.
(1993)
Mol. Cell. Biol.
13,
4860-4874
9.
Pyronnet, S.,
Imataka, H.,
Gingras, A.-C.,
Fukunaga, T.,
Hunter, T.,
and Sonenberg, N.
(1999)
EMBO J.
18,
270-279
10.
Altmann, M.,
Schmitz, N.,
Berset, C.,
and Trachsel, H.
(1997)
EMBO J.
16,
1114-1121
11.
Mader, S.,
Lee, H.,
Pause, A.,
and Sonenberg, N.
(1995)
Mol. Cell. Biol.
15,
4990-4997
12.
Marcotrigiano, J.,
Gingras, A.-C.,
Sonenberg, N.,
and Burley, S. K.
(1999)
Mol. Cell
3,
707-716
13.
Hershey, P. E. C.,
McWhirter, S. M.,
Gross, J. D.,
Wagner, G.,
Alber, T.,
and Sachs, A. B.
(1999)
J. Biol. Chem.
274,
21297-21304
14.
Ptushkina, M.,
von der Haar, T.,
Vasilescu, S.,
Frank, R.,
Birkenhäger, R.,
and McCarthy, J. E. G.
(1998)
EMBO J.
17,
4798-4808
15.
Marcotrigiano, J.,
Gingras, A.-C.,
Sonenberg, N.,
and Burley, S. K.
(1997)
Cell
89,
951-961
16.
Matsuo, H.,
Li, H.,
McGuire, A. M.,
Fletcher, C. M.,
Gingras, A.-C.,
Sonenberg, N.,
and Wagner, G.
(1997)
Nat. Struct. Biol.
4,
717-724
17.
McCarthy, J. E. G.
(1998)
Microbiol. Mol. Biol. Rev.
62,
1492-1553
18.
Le, H.,
Tanguay, R. L.,
Balasta, M. L.,
Wei, C. C.,
Browning, K. S.,
Metz, A. M.,
Goss, D. J.,
and Gallie, D. R.
(1997)
J. Biol. Chem.
272,
16247-16255
19.
Wei, C. C.,
Balasta, M. L.,
Ren, J. H.,
and Goss, D. J.
(1998)
Biochemistry
37,
1910-1916
20.
Ptushkina, M.,
von der Haar, T.,
Karim, Md. M.,
Hughes, J. M. X.,
and McCarthy, J. E. G.
(1999)
EMBO J.
18,
4068-4075
21.
Niedzwiecka-Kormas, A., Chlebicka, L., Jankowska-Anyszka, M.,
Stepinski, J., Dadlez, M., Gingras, A.-C., Marcotrigiano, J.,
Sonenberg, N., Burley, S. K., and Stolarski, R. (1999)
RNA abstract
22.
Minich, W. B.,
Balasta, M. L.,
Goss, D. J.,
and Rhoads, R. E.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
7668-7672
23.
Gingras, A.-C.,
Raught, B.,
and Sonenberg, N.
(1999)
Annu. Rev. Biochem.
68,
913-963
24.
Lang, V.,
Zanchin, N. I. T.,
Lünsdorf, H.,
Tuite, M. F.,
and McCarthy, J. E. G.
(1994)
J. Biol. Chem.
269,
6117-6123
25.
Edery, I.,
Lee, K. A. W.,
and Sonenberg, N.
(1987)
in
Translational Regulation of Gene Expression
(Illan, I., ed)
, pp. 335-366, Plenum Press, New York
26.
Wieczorek, Z.,
Niedzwiecka-Kormas, A.,
Chlebicka, L.,
Jankowska, M.,
Kiraga, K.,
Stepinski, J.,
Dadlez, M.,
Drabent, R.,
Darzynkiewicz, E.,
and Stolarski, R.
(1999)
Z. Naturforsch.
54,
278-284
27.
Sha, M.,
Wang, Y.,
Xiang, T.,
van Heerden, A.,
Browning, K. S.,
and Goss, D. J.
(1995)
J. Biol. Chem.
270,
29904-29909
28.
Carberry, S. E.,
Rhoads, R. E.,
and Goss, D. J.
(1989)
Biochemistry
28,
8078-8083
29.
Vilela, C.,
Velasco, C.,
Ptushkina, M.,
and McCarthy, J. E. G.
(2000)
EMBO J.
19,
4372-4382
30.
Haghighat, A.,
and Sonenberg, N.
(1997)
J. Biol. Chem.
272,
21677-21680
31.
Youtani, T.,
Tomoo, K.,
Ishida, T.,
Miyoshi, H.,
and Miura, K.
(2000)
Biochem. Mol. Biol. Int.
49,
27-31
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
K. Treder, E. L. Pettit Kneller, E. M. Allen, Z. Wang, K. S. Browning, and W. A. Miller The 3' cap-independent translation element of Barley yellow dwarf virus binds eIF4F via the eIF4G subunit to initiate translation RNA, January 1, 2008; 14(1): 134 - 147. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sangthong, J. Hughes, and J. E. G. McCarthy Distributed control for recruitment, scanning and subunit joining steps of translation initiation Nucleic Acids Res., June 28, 2007; 35(11): 3573 - 3580. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Hinton, M. J. Coldwell, G. A. Carpenter, S. J. Morley, and V. M. Pain Functional Analysis of Individual Binding Activities of the Scaffold Protein eIF4G J. Biol. Chem., January 19, 2007; 282(3): 1695 - 1708. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. V. Slepenkov, E. Darzynkiewicz, and R. E. Rhoads Stopped-flow Kinetic Analysis of eIF4E and Phosphorylated eIF4E Binding to Cap Analogs and Capped Oligoribonucleotides: EVIDENCE FOR A ONE-STEP BINDING MECHANISM J. Biol. Chem., May 26, 2006; 281(21): 14927 - 14938. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Magee and J. Warwicker Simulation of non-specific protein-mRNA interactions Nucleic Acids Res., November 27, 2005; 33(21): 6694 - 6699. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Fechter and G. G. Brownlee Recognition of mRNA cap structures by viral and cellular proteins J. Gen. Virol., May 1, 2005; 86(5): 1239 - 1249. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Seal, R. Temperley, J. Wilusz, R. N. Lightowlers, and Z. M. A. Chrzanowska-Lightowlers Serum-deprivation stimulates cap-binding by PARN at the expense of eIF4E, consistent with the observed decrease in mRNA stability Nucleic Acids Res., January 14, 2005; 33(1): 376 - 387. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kahvejian, Y. V. Svitkin, R. Sukarieh, M.-N. M'Boutchou, and N. Sonenberg Mammalian poly(A)-binding protein is a eukaryotic translation initiation factor, which acts via multiple mechanisms Genes & Dev., January 1, 2005; 19(1): 104 - 113. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Caron, M. Charon, E. Cramer, N. Sonenberg, and I. Dusanter-Fourt Selective Modification of Eukaryotic Initiation Factor 4F (eIF4F) at the Onset of Cell Differentiation: Recruitment of eIF4GII and Long-Lasting Phosphorylation of eIF4E Mol. Cell. Biol., June 1, 2004; 24(11): 4920 - 4928. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Mendelsohn, A.-m. Li, C. A. Vargas, K. Riehman, A. Watson, and J. L. Fridovich-Keil Genetic and biochemical interactions between SCP160 and EAP1 in yeast Nucleic Acids Res., October 15, 2003; 31(20): 5838 - 5847. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. He, T. von der Haar, C. R. Singh, M. Ii, B. Li, A. G. Hinnebusch, J. E. G. McCarthy, and K. Asano The Yeast Eukaryotic Initiation Factor 4G (eIF4G) HEAT Domain Interacts with eIF1 and eIF5 and Is Involved in Stringent AUG Selection Mol. Cell. Biol., August 1, 2003; 23(15): 5431 - 5445. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Scheper, B. van Kollenburg, J. Hu, Y. Luo, D. J. Goss, and C. G. Proud Phosphorylation of Eukaryotic Initiation Factor 4E Markedly Reduces Its Affinity for Capped mRNA J. Biol. Chem., January 25, 2002; 277(5): 3303 - 3309. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ptushkina, K. Berthelot, T. von der Haar, L. Geffers, J. Warwicker, and J. E. G. McCarthy A second eIF4E protein in Schizosaccharomyces pombe has distinct eIF4G-binding properties Nucleic Acids Res., November 15, 2001; 29(22): 4561 - 4569. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Karim, J. M. X. Hughes, J. Warwicker, G. C. Scheper, C. G. Proud, and J. E. G. McCarthy A Quantitative Molecular Model for Modulation of Mammalian Translation by the eIF4E-binding Protein 1 J. Biol. Chem., June 1, 2001; 276(23): 20750 - 20757. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||